Show simple item record

dc.contributor.authorLee, C.
dc.contributor.authorFerris, D. J.
dc.contributor.authorBarrett, M. F.
dc.contributor.authorKisiday, John D.
dc.contributor.authorFrisbie, D. D.
dc.contributor.authorMiller, Rachel Elizabeth
dc.contributor.authorGrodzinsky, Alan J.
dc.contributor.authorVanderploeg, Eric J.
dc.date.accessioned2015-10-07T16:39:27Z
dc.date.available2015-10-07T16:39:27Z
dc.date.issued2010-09
dc.date.submitted2009-12
dc.identifier.issn10634584
dc.identifier.issn1522-9653
dc.identifier.urihttp://hdl.handle.net/1721.1/99189
dc.description.abstractObjective The goal of this study was to test the ability of an injectable self-assembling peptide (KLD) hydrogel with or without chondrogenic factors (CF) and allogeneic bone marrow stromal cells (BMSCs) to stimulate cartilage regeneration in a full-thickness, critically-sized, rabbit cartilage defect model in vivo. We used CF treatments to test the hypotheses that CF would stimulate chondrogenesis and matrix production by cells migrating into acellular KLD (KLD + CF) or by BMSCs delivered in KLD (KLD + CF + BMSCs). Design Three groups were tested against contralateral untreated controls: KLD, KLD + CF, and KLD + CF +BMSCs, n = 6–7. Transforming growth factor-β1 (TGF-β1), dexamethasone, and insulin-like growth factor-1 (IGF-1) were used as CF pre-mixed with KLD and BMSCs before injection. Evaluations included gross, histological, immunohistochemical and radiographic analyses. Results KLD without CF or BMSCs showed the greatest repair after 12 weeks with significantly higher Safranin-O, collagen II immunostaining, and cumulative histology scores than untreated contralateral controls. KLD + CF resulted in significantly higher aggrecan immunostaining than untreated contralateral controls. Including allogeneic BMSCs + CF markedly reduced the quality of repair and increased osteophyte formation compared to KLD-alone. Conclusions These data show that KLD can fill full-thickness osteochondral defects in situ and improve cartilage repair as shown by Safranin-O, collagen II immunostaining, and cumulative histology. In this small animal model, the full-thickness critically-sized defect provided access to the marrow, similar in concept to abrasion arthroplasty or spongialization in large animal models, and suggests that combining KLD with these techniques may improve current practice.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (National Institute for Biomedical Imaging and Bioengineering (U.S.) Grant EB003805)en_US
dc.description.sponsorshipAmerican Society for Engineering Education. National Defense Science and Engineering Graduate Fellowshipen_US
dc.description.sponsorshipNational Science Foundation (U.S.). Graduate Research Fellowshipen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant EB003805)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant AR33236)en_US
dc.description.sponsorshipArthritis Foundation (Postdoctoral Fellowship)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.joca.2010.09.004en_US
dc.rightsCreative Commons Attribution-Noncommercial-NoDerivativesen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleEffect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repairen_US
dc.typeArticleen_US
dc.identifier.citationMiller, R.E., A.J. Grodzinsky, E.J. Vanderploeg, C. Lee, D.J. Ferris, M.F. Barrett, J.D. Kisiday, and D.D. Frisbie. “Effect of Self-Assembling Peptide, Chondrogenic Factors, and Bone Marrow-Derived Stromal Cells on Osteochondral Repair.” Osteoarthritis and Cartilage 18, no. 12 (December 2010): 1608–1619.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Center for Biomedical Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.mitauthorMiller, Rachel Elizabethen_US
dc.contributor.mitauthorGrodzinsky, Alan J.en_US
dc.contributor.mitauthorVanderploeg, Eric J.en_US
dc.relation.journalOsteoarthritis and Cartilageen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMiller, R.E.; Grodzinsky, A.J.; Vanderploeg, E.J.; Lee, C.; Ferris, D.J.; Barrett, M.F.; Kisiday, J.D.; Frisbie, D.D.en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-8911-7998
dc.identifier.orcidhttps://orcid.org/0000-0002-4942-3456
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record